NewsBenzingaコシエンス・バイオファーマ、第3四半期EPSは(3.45ドル)で前年同期の(1.72ドル)から悪化、売上高は251.6万ドルで前年同期の147.6万ドルから増加 コシエンス・バイオファーマ、第3四半期EPSは(3.45ドル)で前年同期の(1.72ドル)から悪化、売上高は251.6万ドルで前年同期の147.6万ドルから増加 Benzinga 2026.11.13 21:32 (GMT+0) Open on Benzinga Other news T1 Energy Stock Plunges: What's Going On? Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT Nike CEO Says Co Aims To Double The Units Of Product Created In Under 14 Months By FY31